Skip to main content
Published: Aug 03, 2022
Wilmington, Delaware, United States, Transparency Market Research Inc.: This report analyzes the current scenario and future prospects of the global platelet rich plasma market. Increase in awareness about platelet rich plasma therapies, rise in prevalence of various orthopedic diseases, and surge in demand for effective hair-loss treatment are the key factors projected to propel the global platelet rich plasma market during the forecast period.
Advantages and applications of PRP therapy over conventional wound healing and disease treatments, such as surgery and medicines, have resulted in higher demand for PRP products globally.
Autologous Activated Platelet Rich Plasma Holds Potential in COVID-19 Treatment
Research studies from Indonesia are grabbing the attention of stakeholders in the platelet rich plasma market. Due to the increasing number of COVID-19 cases in Indonesia, autologous activated platelet-rich plasma (aaPRP) has been gaining recognition for potentials in suppressing cytokine release syndrome (CRS) in patients. Since cytokine storm has been a typical symptom among coronavirus patients in Indonesia, intravenous autologous activated platelet-rich plasma holds promising potentials to reduce death rates.
Postponement and rescheduling of medical treatments have affected revenue flow in the platelet rich plasma market during the ongoing pandemic. Nevertheless, companies are implementing comprehensive vendor reviews to ensure robust medical supplies at healthcare facilities. They are reviewing processes for monitoring expiration dates and replace old supplies with new ones.
Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4021
Need for Official FDA Approval in End-use Cases Hampers Market Growth
The platelet rich plasma market is expected to reach the valuation of US$ 815.3 Mn by 2031. Although the equipment used to produce PRP and the injections have been cleared by the FDA (Food and Drug Administration), this procedure is considered investigational and has not been officially approved by the FDA for many uses. Nevertheless, PRP is a low-risk procedure and linked with minor side effects.
Outside of the orthopedic treatment, PRP is being used for the treatment of hair loss, for skin rejuvenation, and post-surgical healing. Healthcare companies are establishing stable revenue streams with the help of PRP injections meant for tendon, muscle, and join injuries.
Dramatic Skin Improvement with Cosmetic PRP Creating Revenue Opportunities
The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period. The American Society of Plastic Surgeons has been witnessing a significant increase in the use of cosmetic PRP in the past few years. This is evident, as treatments using PRP show great promise for harnessing the body’s own natural tissue repair processes to help patients achieve improved form and function.
Platelet rich plasma is being prepared by manufacturers in the platelet rich plasma market with the help of various methods such as centrifugation, which involves spinning a small sample of the patient’s blood into separate components, followed by other steps. The growing popularity of vampire facial consisting of non-surgical microneedling followed by topical application of PRP is creating revenue opportunities for market stakeholders.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4021
PRP Improves Patient Quality of Life with Prevention of Orthopedic Surgery
Since PRP mimics the body’s natural healing process, companies in the platelet rich plasma market are tapping incremental opportunities in orthopedics. Increased levels of platelets lead to increased growth factors, which have the potential to improve signaling and recruitment of cells to promote quicker & efficient healing in complex orthopedic conditions in patients.
AOA Orthopedic Specialists has been gaining recognition for increasing the availability of PRP in order to either delay or prevent an orthopedic surgery or to use in conjunction with the surgery.
Platelet Rich Plasma Market: Key Segments
In terms of sample type, the global platelet rich plasma market has been classified pure PRP, leukocyte-rich PRP, and pure PRF. The pure PRP segment is projected to account for major share of the global platelet rich plasma market in the near future. The segment’s dominance can be ascribed to technological advancements of PRP devices leading to the use of pure PRP in various cases and rich platelet content are anticipated to boost the growth of the segment in the next few years. Technological advancements such as smart home diagnostic kits has also boosted the growth of the global market.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=4021
Based on origin, the global platelet rich plasma market has been categorized into autologous, allogenic, and homologus. The autologous segment dominated the global platelet rich plasma market in 2020. Autologous PRP is a safe, simple, and cost-efficient approach and has positive effect on cell proliferation, migration, and angiogenesis. Autologous PRP is quite beneficial in the treatment of chronic non-healing ulcers. This is expected to drive the demand for autologous PRP, especially in developed countries across the globe.
In terms of application, the global platelet rich plasma market has been segregated into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. The orthopedic surgery is likely to account for major share of the global platelet rich plasma market during the forecast period. Rise in the number of orthopedic surgeries is projected to drive the segment during of the forecast period.
CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year
Platelet Rich Plasma Market: Regional Outlook
In terms of region, the global platelet rich plasma market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The platelet rich plasma market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The platelet rich plasma market study also covers the competitive scenario across the globe.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4021
Companies Covered in Platelet Rich Plasma Market Report
Key players operating in the global platelet rich plasma market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
Major companies profiled in the platelet rich plasma market report are
More Trending Reports by Transparency Market Research –
Cell Culture Market: The global cell culture market is expected to reach the value of US$ 27.6 Bn by the end of 2031. It is estimated to expand at a CAGR of 9% from 2021 to 2031.
Amniotic Membrane Market: The global amniotic membrane market is projected to expand at a healthy CARG of ~10% from 2019 to 2027.
In-vitro Transcription Templates Market: The global in-vitro transcription templates market is expected to expand at a CAGR of ~20% from 2021 to 2030.
Human Microbiome Market: The global human microbiome market is expected to reach the value of US$ 2.2 Bn by the end of 2028.
Hematology Diagnostics Market: The global hematology diagnostics market was valued at approximately US$ 3,495.0 Mn in 2017 and is anticipated to reach approximately US$ 5,586.4 Mn by 2026.
Diagnostic Specialty Enzymes Market: The global diagnostic specialty enzymes market was valued at US$ 686.2 Mn in 2017 and is anticipated to expand at a CAGR of 7.5% from 2018 to 2026 to reach US$ 1401.7 Mn by 2026.
Immunoassay Market: Growing geriatric population across the world is anticipated to be a key driving factor for immunoassay market at global level.
Wearable Medical Devices Market: Increasing penetration of technology to render healthcare, increase in number of healthcare companies, growing patient population, and rise in product approvals are fueling the growth of wearable medical devices market.
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Back to news
Back to top
© 1985 – 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software
Platelet-rich Plasma Market: Rise in Emphasis on Post-Surgical Repairs Drives Market – BioSpace
Skip to main content